Thoughts on the Coming Year, ISGIO, and the Future of GI Oncology

Por Haller, Daniel G.
Publicado em 2009

What Makes GI Oncology Special?

Por Haller, Daniel G.
Publicado em 2009

The International Society of Gastrointestinal Oncology Selected Proceedings and Abstracts from the Sixth Annual Conference

Por Haller, Daniel G.
Publicado em 2010

The Heart of the Matter

Por Haller, Daniel G.
Publicado em 2011

Must Reading for GI Oncologists

Por Haller, Daniel G.
Publicado em 2011

Keep Those Cards and Letters Coming!

Por Haller, Daniel G.
Publicado em 2012

The Past and Future of GI Oncology Research

Por Haller, Daniel G.
Publicado em 2012

A Call for Opinions

Por Haller, Daniel G.
Publicado em 2013

Colorectal Cancer Treatment in the Elderly: Tailored Therapy Approaches

Por Avadhani, Anjali N., Haller, Daniel G.
Publicado em 2007

Accomplishments in 2007 in the Adjuvant Treatment of Colorectal Cancer

Por de Gramont, Aimery, Haller, Daniel G.
Publicado em 2008

Accomplishments in Gastrointestinal Oncology in 2007: Conclusion

Por de Gramont, Aimery, Haller, Daniel G.
Publicado em 2008

Provisional Clinical Opinion

Por Haller, Daniel G., Cox, John V.
Publicado em 2009

Adjuvant Therapy for Stage II and III Colon Cancer: Consensus Report of the International Society of Gastrointestinal Oncology

Por Marshall, John L., Haller, Daniel G., de Gramont, Aimery, Hochster, Howard S., Lenz, Heinz-Josef, Ajani, Jaffer A., Goldberg, Richard M.
Publicado em 2007

MOLECULAR PREDICTORS OF SURVIVAL AFTER ADJUVANT CHEMOTHERAPY FOR COLON CANCER

Por Watanabe, Toshiaki, Wu, Tsung-Teh, Catalano, Paul J., Ueki, Takashi, Satriano, Robert, Haller, Daniel G., Benson, Al B., Hamilton, Stanley R.
Publicado em 2001

Phase I Study of Preoperative Radiation Therapy with Concurrent Infusional 5-Fluorouracil and Oxaliplatin followed by Surgery and Postoperative 5- Fluorouracil plus Leucovorin for...

Por Rosenthal, David I., Catalano, Paul J., Haller, Daniel G., Landry, Jerome C., Sigurdson, Elin R., Spitz, Francis R., Benson, Al Bowen
Publicado em 2008

Ten Recommendations for Closing the Credibility Gap in Reporting Industry-Sponsored Clinical Research: A Joint Journal and Pharmaceutical Industry Perspective

Por Mansi, Bernadette A., Clark, Juli, David, Frank S., Gesell, Thomas M., Glasser, Susan, Gonzalez, John, Haller, Daniel G., Laine, Christine, Miller, Charles L., Mooney, LaVerne A., Zecevic, Maja
Publicado em 2012

Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Col...

Por Shah, Manish A., Renfro, Lindsay A., Allegra, Carmen J., André, Thierry, de Gramont, Aimery, Schmoll, Hans-Joachim, Haller, Daniel G., Alberts, Steven R., Yothers, Greg, Sargent, Daniel J.
Publicado no J Clin Oncol (2016)

Impact of Age on the Efficacy of Newer Adjuvant Therapies in Patients With Stage II/III Colon Cancer: Findings From the ACCENT Database

Por McCleary, Nadine J., Meyerhardt, Jeffrey A., Green, Erin, Yothers, Greg, de Gramont, Aimery, Van Cutsem, Eric, O'Connell, Michael, Twelves, Christopher J., Saltz, Leonard B., Haller, Daniel G., Sargent, Daniel J.
Publicado em 2013

Comparison of Outcomes After Fluorouracil-Based Adjuvant Therapy for Stages II and III Colon Cancer Between 1978 to 1995 and 1996 to 2007: Evidence of Stage Migration From the ACCE...

Por Shi, Qian, Andre, Thierry, Grothey, Axel, Yothers, Greg, Hamilton, Stanley R., Bot, Brian M., Haller, Daniel G., Van Cutsem, Eric, Twelves, Chris, Benedetti, Jacqueline K., O'Connell, Michael J., Sargent, Daniel J.
Publicado em 2013

Phase II Trial of Paclitaxel/Cisplatin Followed by Surgery and Adjuvant Radiation Therapy and 5-Fluorouracil/Leucovorin for Gastric Cancer (ECOG E7296)

Por Chakravarthy, A. Bapsi, Catalano, Paul J., Mondschein, Joshua K., Rosenthal, David I., Haller, Daniel G., Whittington, Richard, Spitz, Francis R., Wagner, Henry, Sigurdson, Elin R., Tschetter, Loren K., Bayer, Gerald K., Mulcahy, Mary F., Benson, Al B.
Publicado em 2012